Atlas Trials

A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

Clinical trial NCT02353936 · UNKNOWN

Trial details

NCT number
NCT02353936
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of Esophagus
Start date
2015-01-01
Primary completion
2020-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.